Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chasing Science is a Barcelona-based biomedical venture builder that specializes in transforming scientific research into high-impact biotechnology companies. Founded in 2017, the firm provides hands-on support in company creation, fundraising, and strategic development, focusing on novel therapeutics and platform technologies. Their portfolio includes innovative startups such as Nanobots Therapeutics, Oniria Therapeutics, and Connecta Therapeutics, which address unmet needs in oncology, ophthalmology, and age-related diseases. By bridging the gap between academia and industry, Chasing Science accelerates the translation of breakthrough discoveries into clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chasing Science.